234 related articles for article (PubMed ID: 24060154)
1. Concurrent expression of cyclo-oxygenase-2 and epidermal growth factor receptor in canine malignant mammary tumours.
Guimarães MJ; Carvalho MI; Pires I; Prada J; Gil AG; Lopes C; Queiroga FL
J Comp Pathol; 2014 Jan; 150(1):27-34. PubMed ID: 24060154
[TBL] [Abstract][Full Text] [Related]
2. EGFR and microvessel density in canine malignant mammary tumours.
Carvalho MI; Guimarães MJ; Pires I; Prada J; Silva-Carvalho R; Lopes C; Queiroga FL
Res Vet Sci; 2013 Dec; 95(3):1094-9. PubMed ID: 24091029
[TBL] [Abstract][Full Text] [Related]
3. Positive Interplay Between CD3+ T-lymphocytes and Concurrent COX-2/EGFR Expression in Canine Malignant Mammary Tumors.
Carvalho MI; Pires I; Prada J; Ferreira AF; Queiroga FL
Anticancer Res; 2015 May; 35(5):2915-20. PubMed ID: 25964576
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical expression of Epidermal Growth Factor Receptor (EGFR) in canine mammary tissues.
Gama A; Gärtner F; Alves A; Schmitt F
Res Vet Sci; 2009 Dec; 87(3):432-7. PubMed ID: 19464036
[TBL] [Abstract][Full Text] [Related]
5. MUC1 expression in canine malignant mammary tumours and relationship to clinicopathological features.
de Oliveira JT; Pinho SS; de Matos AJ; Hespanhol V; Reis CA; Gärtner F
Vet J; 2009 Dec; 182(3):491-3. PubMed ID: 18948041
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical expression of vascular endothelial growth factor in canine mammary tumours.
Santos AA; Oliveira JT; Lopes CC; Amorim IF; Vicente CM; Gärtner FR; Matos AJ
J Comp Pathol; 2010 Nov; 143(4):268-75. PubMed ID: 20570280
[TBL] [Abstract][Full Text] [Related]
7. The role of Cox-2 expression in the prognosis of dogs with malignant mammary tumours.
Queiroga FL; Pires I; Lobo L; Lopes CS
Res Vet Sci; 2010 Jun; 88(3):441-5. PubMed ID: 19939424
[TBL] [Abstract][Full Text] [Related]
8. Different role of COX-2 and angiogenesis in canine inflammatory and non-inflammatory mammary cancer.
Clemente M; Sánchez-Archidona AR; Sardón D; Díez L; Martín-Ruiz A; Caceres S; Sassi F; Dolores Pérez-Alenza M; Illera JC; Dunner S; Peña L
Vet J; 2013 Aug; 197(2):427-32. PubMed ID: 23489848
[TBL] [Abstract][Full Text] [Related]
9. High COX-2 expression is associated with increased angiogenesis, proliferation and tumoural inflammatory infiltrate in canine malignant mammary tumours: a multivariate survival study.
Carvalho MI; Pires I; Prada J; Raposo TP; Gregório H; Lobo L; Queiroga FL
Vet Comp Oncol; 2017 Jun; 15(2):619-631. PubMed ID: 26792550
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical expression of caveolin-1 in normal and neoplastic canine mammary tissue.
Amorim I; Lopes CC; Faustino AM; Pereira PD
J Comp Pathol; 2010 Jul; 143(1):39-44. PubMed ID: 20153867
[TBL] [Abstract][Full Text] [Related]
11. The potential role of COX-2 in cancer stem cell-mediated canine mammary tumor initiation: an immunohistochemical study.
Huang J; Zhang D; Xie F; Lin D
J Vet Sci; 2015; 16(2):225-31. PubMed ID: 26124697
[TBL] [Abstract][Full Text] [Related]
12. Expression of Cox-1 and Cox-2 in canine mammary tumours.
Queiroga FL; Alves A; Pires I; Lopes C
J Comp Pathol; 2007; 136(2-3):177-85. PubMed ID: 17416236
[TBL] [Abstract][Full Text] [Related]
13. HER-2 expression in canine morphologically normal, hyperplastic and neoplastic mammary tissues and its correlation with the clinical outcome.
Ressel L; Puleio R; Loria GR; Vannozzi I; Millanta F; Caracappa S; Poli A
Res Vet Sci; 2013 Apr; 94(2):299-305. PubMed ID: 23141215
[TBL] [Abstract][Full Text] [Related]
14. Expression of iNOS, COX-2 and VEGF in canine mammary tumours and non-neoplastic mammary glands: Association with clinicopathological features and tumour grade.
Anadol E; Yar Saglam AS; Gultiken N; Karakas K; Alcigir E; Alkan H; Kanca H
Acta Vet Hung; 2017 Sep; 65(3):382-393. PubMed ID: 28956485
[TBL] [Abstract][Full Text] [Related]
15. COX-2 over-expression correlates with VEGF and tumour angiogenesis in canine mammary cancer.
Queiroga FL; Pires I; Parente M; Gregório H; Lopes CS
Vet J; 2011 Jul; 189(1):77-82. PubMed ID: 20675158
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of immunohistochemical markers and histological classification in malignant canine mammary tumours.
Pastor N; Ezquerra LJ; Santella M; Caballé NC; Tarazona R; Durán ME
Vet Comp Oncol; 2020 Dec; 18(4):753-762. PubMed ID: 32336005
[TBL] [Abstract][Full Text] [Related]
17. Lymphangiogenesis in canine mammary tumours: a morphometric and prognostic study.
Sleeckx N; Van Brantegem L; Van den Eynden G; Fransen E; Casteleyn C; Van Cruchten S; Veldhuis Kroeze E; Van Ginneken C
J Comp Pathol; 2014; 150(2-3):184-93. PubMed ID: 24225342
[TBL] [Abstract][Full Text] [Related]
18. Expression and prognostic value of c-met in canine mammary tumours.
Chen YC; Chen YY; Liao JW; Chang SC
Vet Comp Oncol; 2018 Dec; 16(4):670-676. PubMed ID: 30129270
[TBL] [Abstract][Full Text] [Related]
19. COX-2, mPGES-1 and EP2 receptor immunohistochemical expression in canine and feline malignant mammary tumours.
Millanta F; Asproni P; Canale A; Citi S; Poli A
Vet Comp Oncol; 2016 Sep; 14(3):270-80. PubMed ID: 24824420
[TBL] [Abstract][Full Text] [Related]
20. Expression of TopBP1 in canine mammary neoplasia in relation to histological type, Ki67, ERalpha and p53.
Morris JS; Nixon C; King OJ; Morgan IM; Philbey AW
Vet J; 2009 Mar; 179(3):422-9. PubMed ID: 18314357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]